住院心力衰竭的结果轨迹与保存的喷射分数:一个机器学习集群分析分析
Marco Spagnolin1, Luca Fazzini2, Cinzia Giaccherini3
1Division of Cardiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
European journal of heart failure
|February 25, 2026
概括
集群分析确定了住院后心力衰竭与保留射出分数 (HFpEF) 的三个不同的风险组. 这种方法可以为HFpEF患者提供个性化的护理,改善资源配置和结果.
科学领域:
- 心脏病学 心脏病学
- 医疗信息学 医疗信息学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 建议在心力衰竭 (HHF) 住院后进行密集的随访,但实施起来具有挑战性.
- 为了更好地分配资源,需要对具有保留射出分数 (HFpEF) 的HHF进行风险分层.
- 没有任何研究在HFpEF风险分层的急性环境中使用集群分析.
研究的目的:
- 应用集群分析来识别急性HFpEF的不同表型.
- 为了对住院HFpEF患者的风险进行分层.
- 探索个性化管理策略的潜力.
主要方法:
- 对471名住院的HFpEF患者 (左心室喷射率>40%) 进行了集群分析.
- 在12个月后,评估了死亡,紧急心脏移植,HF住院或ED访问去补偿的HF的复合终点.
- 考克斯回归和分类以及回归树分析确定了不良结果的预测因素.
主要成果:
- 根据临床变量,并发症和生物标志物,确定了三个不同的HFpEF患者群.
- 集群1:年轻,de novo HF,较少的并发病,保留功能,较低的BNP和NLR.
- 集群2:老年妇女,高血压,心房动 (HR 2.9与HR 2.9对比). 集群 1). 集群 1). 集群 1).
- 集群3:年龄较大,HF恶化,较高的NYHA类,功能障碍,贫血,BNP和NLR升高 (HR 4.8与NLR相比). 集群 1). 集群 1). 集群 1).
- NYHA类和中性粒细胞-淋巴细胞比率 (NLR) 是关键的预后指标.
结论:
- 集群分析成功地在急性环境中确定了低风险,中风险和高风险的HFpEF表型.
- 这些已识别的表型可以指导住院HFpEF患者的个性化管理策略.
- 进一步的研究可以验证这些集群用于临床决策和资源分配.
相关概念视频
01:30Heart Failure IV: Classification and Diagnostic Evaluation
482
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
482
01:17Pathophysiology of Heart Failure
4.2K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.2K
01:29Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
01:26Heart Failure III: Clinical Manifestations
719
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
719
01:27Heart Failure I: Introduction
1.0K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.0K
01:30Heart Failure V: Medical Management
419
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
419